SCHEMBL19188136

SCHEMBL19188136

CCOC(=O)c1cc2cc(Br)cc(CBr)c2o1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 3/20 0.44
MAOB P27338 2/20 0.41
AKR1B1 P15121 1/20 0.40
MAPK1 P28482 1/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38
TARBP2 Q15633 1/20 0.38
KDM4E B2RXH2 4/20 0.37
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
PIM2 Q9P1W9 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19188111 0.85 PIM1 (0.47) PIM1MAOBAKR1B1MAPK1TARBP2
SCHEMBL21230746 0.85 MAOB (0.52) PIM1MAOBAKR1B1TARBP2MAPT
SCHEMBL13725141 0.82 PIM1 (0.45) PIM1MAOBAKR1B1TARBP2NPC1
SCHEMBL16345194 0.82 MAOB (0.47) PIM1MAOBAKR1B1CYP4F2CYP4A11
SCHEMBL5309471 0.81 KDM4E (0.51) MAOBAKR1B1MAPK1CYP4F2CYP4A11
SCHEMBL7389995 0.81 PIM1 (0.68) PIM1MAOBMAPK1MAPTMEN1
SCHEMBL19188207 0.80 PIM1 (0.43) PIM1MAOBAKR1B1MAPK1TARBP2
SCHEMBL1982581 0.79 GPR35 (0.53) PIM1MAOBMAPK1KDM4EMAPT
SCHEMBL29852905 0.79 GPR35 (0.53) PIM1MAOBMAPK1KDM4EMAPT
SCHEMBL19187917 0.79 ALDH1A1 (0.47) PIM1MAOBAKR1B1TARBP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170240519-A1 BENZOFURAN ANALOGUE AS NS4B INHIBITOR CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-08-24 US disclosed
US-20170240519-A1 BENZOFURAN ANALOGUE AS NS4B INHIBITOR CHANGZHOU YINSHENG PHARMACEUTICAL CO., LTD. (CN) 2017-08-24 US disclosed
EP-3199530-A1 BENZOFURAN ANALOGUE AS NS4B INHIBITOR Changzhou Yinsheng Pharmaceutical Co., Ltd. (CN) 2017-08-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170240519-A1 BENZOFURAN ANALOGUE AS NS4B INHIBITOR GTF3C4, BRD4, CUL4B PIM1 3321/4885MAOB 1488/4885AKR1B1 2626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.